HGEN in EU Commission 10 Most Promising Treatments for COVID-19!

European Commission’s independent experts selected Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19!

CEO of Humanigen said today: "We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19".

In the same list you can see Pfizer, Roche, Astra Zeneca and Eli Lilly! Humanigen is the smallest company.

Institutions loaded big on this dip of Humanigen, Inc. (HGEN), 132Mil in the last quarter!
On 8/23/2021 Morgan Stanley reported an increased ownership in HGEN by +1,884.6%!
Biggest shareholder is Blackrock with 3,037,693 shares worth $52.80Mil, which increased its position by +283.5% for a total ownership of 5.141% of Humanigen.

So Blackrock paid an average of 17.3usd per share!

The price of the stock is now 6.60usd!

H.C. Wainwright’s Joseph Pantginis rates HGEN a Buy along with a $28 price target and said the market overreacted on that selloff.

My price target is the 16.3usd resistance!